DPP4 and Miyoshi myopathy: CD26, known to be involved in metastasis and progression of cancers, is highly expressed in MM, and anti-CD26 mAb inhibited tumor growth in vivo, suggesting that it could be used as a therapeutic target for MM [30,31].